| |
| |
|
| Insider
Information: |
Thompson Jaye |
| Relationship: |
VP Clinical Reg Affairs |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
260,348 |
|
|
Indirect Shares
|
4,313 |
|
|
| Direct
Value |
$3,400,145 |
|
|
|
Indirect Value
|
$2,847 |
|
|
| Total
Shares |
264,661 |
|
|
| Total
Value |
$3,402,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
17
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
14
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -15.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acer Therapeutics Inc |
ACER |
Officer |
|
0 |
2009-11-18 |
4,313 |
Premium* |
|
|
Greenwich Lifesciences, Inc. |
GLSI |
VP Clinical Reg Affairs |
2023-10-27 |
260,348 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-10-27 |
4 |
B |
$8.57 |
$4,285 |
D/D |
500 |
260,348 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-09-26 |
4 |
B |
$8.71 |
$5,226 |
D/D |
600 |
259,848 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-07-13 |
4 |
B |
$9.49 |
$2,373 |
D/D |
250 |
259,248 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-04-28 |
4 |
B |
$11.22 |
$2,805 |
D/D |
250 |
258,998 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-04-11 |
4 |
B |
$11.87 |
$11,870 |
D/D |
1,000 |
258,745 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-03-15 |
4 |
B |
$12.71 |
$3,178 |
D/D |
250 |
257,745 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-02-24 |
4 |
B |
$15.40 |
$3,849 |
D/D |
250 |
257,495 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-02-03 |
4 |
B |
$20.84 |
$5,210 |
D/D |
250 |
257,245 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-01-27 |
4 |
B |
$19.20 |
$4,800 |
D/D |
250 |
256,995 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2023-01-13 |
4 |
B |
$16.50 |
$4,125 |
D/D |
250 |
256,745 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2022-12-16 |
4 |
B |
$12.94 |
$3,235 |
D/D |
250 |
256,495 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2022-12-02 |
4 |
B |
$13.98 |
$3,495 |
D/D |
250 |
256,245 |
2.66 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2022-04-19 |
4 |
B |
$16.74 |
$8,370 |
D/D |
500 |
255,995 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2022-01-31 |
4 |
B |
$18.47 |
$9,235 |
D/D |
500 |
255,495 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg Affairs |
• – – |
2022-01-21 |
4 |
B |
$16.33 |
$8,165 |
D/D |
500 |
254,995 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg. Affairs |
• – – |
2022-01-18 |
4 |
B |
$18.87 |
$9,435 |
D/D |
500 |
254,495 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical Reg. Affairs |
• – – |
2022-01-13 |
4 |
B |
$19.99 |
$19,990 |
D/D |
1,000 |
253,995 |
2.74 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical & Reg. AffairsOffi |
• – – |
2021-12-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
252,995 |
|
% |
|
| GLSI |
Greenwich Lifesciences, I... |
VP Clinical & Reg AffairsOffic |
• – – |
2020-09-24 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
252,810 |
|
- |
|
| GLSI |
Greenwich Lifesciences, I... |
VPC AND REGULATORY AFFAIRSOffi |
• – – |
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
140,450 |
|
- |
|
| ACER |
Acer Therapeutics Inc |
Sr VP Clin Dev & Reg AffairsOf |
• – – |
2009-11-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,313 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
